[Federal Register Volume 62, Number 24 (Wednesday, February 5, 1997)]
[Notices]
[Pages 5423-5428]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-2799]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES
[Announcement 721]


State and Community-Based Childhood Lead Poisoning Prevention 
Program and Surveillance of Blood Lead Levels in Children; Notice of 
Availability of Funds for Fiscal Year 1997

Introduction

    The Centers for Disease Control and Prevention (CDC) announces the 
availability of funds in fiscal year (FY) 1997 for new and competing 
continuation State and community-based childhood lead poisoning 
prevention projects, and to build statewide capacity to conduct 
surveillance of blood lead levels in children.
    The CDC is committed to achieving the health promotion and disease 
prevention objectives of Healthy People 2000, a national activity to 
reduce morbidity and mortality and improve the quality of life. This 
announcement is related to the priority area of Environmental Health. 
(To order a copy of Healthy People 2000, see the Where to Obtain 
Additional Information section.)

[[Page 5424]]

Authority

    This program is authorized under sections 301(a), 317A and 317B of 
the Public Health Service Act [42 U.S.C. 241(a), 247b-1, and 247b-3], 
as amended. Program regulations are set forth in Title 42, Code of 
Federal Regulations, Part 51b.

Smoke-Free Workplace

    The CDC strongly encourages all grant recipients to provide a 
smoke-free workplace and promote the non-use of all tobacco products, 
and Public Law 103-227, the Pro-Children Act of 1994, prohibits smoking 
in certain facilities that receive Federal funds in which education, 
library, day care, health care, and early childhood development 
services are provided to children.

Environmental Justice Initiative

    Activities conducted under this announcement should be consistent 
with the Federal Executive Order No. 12898 entitled, ``Federal Actions 
to Address Environmental Justice in Minority Populations and Low-Income 
Populations.'' Grantees, to the greatest extent practicable and 
permitted by law, shall make achieving environmental justice part of 
its program's mission by identifying and addressing, as appropriate, 
disproportionately high and adverse human health and environmental 
effects of lead on minority populations and low-income populations.

Eligible Applicants

    Eligible applicants for State childhood lead prevention programs 
are State health departments or other State health agencies or 
departments deemed most appropriate by the State to direct and 
coordinate the State's childhood lead poisoning prevention program, and 
agencies or units of local government that serve jurisdictional 
populations greater than 500,000. This eligibility includes health 
departments or other official organizational authority (agency or 
instrumentality) of the District of Columbia, the Commonwealth of 
Puerto Rico, and any territory or possession of the United States.
    Applicants for prevention program grants from eligible units of 
local jurisdiction must elect either to apply directly to CDC as a 
grantee, or to apply as part of a statewide grant application. Local 
jurisdictions cannot submit applications directly to CDC and also apply 
as part of a Statewide grant application.

For Surveillance Funds Only

    Eligible applicants are State health departments or other State 
health agencies or departments deemed most appropriate by the State to 
direct and coordinate the State's childhood lead poisoning prevention 
and surveillance program. Eligible applicants must have regulations for 
reporting of PbB levels by both public and private laboratories or 
provide assurances that such regulations will be in place within six 
months of awarding the grant. This program is intended to initiate and 
build capacity for surveillance of childhood PbB levels. Therefore, any 
applicant that already has in place a PbB level surveillance activity 
must demonstrate how these grant funds will be used to enhance, expand 
or improve the current activity, in order to remain eligible for 
funding. CDC funds should be added to blood-lead surveillance funding 
from other sources, if such funding exists. Funds for these programs 
may not be used in place of any existing funding for surveillance of 
PbB levels.
    If a State agency applying for grant funds is other than the 
official State health department, written concurrence by the State 
health department must be provided.

Availability of Funds

State and Community-based Prevention Program Grant Funds

    Approximately $8,000,000 will be available in FY 1997 to fund a 
selected number of new and competing continuation childhood lead 
poisoning prevention projects. The CDC anticipates that awards for the 
first budget year will range from $200,000 to $1,500,000. Applications 
exceeding the funding limit of $1,500,000 will be returned as non-
responsive to the program announcement. This includes both direct and 
indirect cost amounts.

Surveillance Grant Funds

    Approximately $300,000 will be available in FY 1997 to fund up to 
four new grants to support the development of PbB surveillance 
activities. Surveillance awards are expected to range from $60,000 to 
$75,000. Applications exceeding the funding limit of $75,000 will be 
returned as non-responsive to the program announcement. This includes 
both direct and indirect cost amounts.
    The new awards are expected to begin on or about July 1, 1997.
    New awards are made for 12-month budget periods within project 
periods not to exceed 3 years. Estimates outlined above are subject to 
change based on the actual availability of funds and the scope and 
quality of applications received. Continuation awards within the 
project period will be made on the basis of satisfactory progress and 
availability of funds.
    Grant awards cannot supplant existing funding for childhood lead 
poisoning prevention programs or surveillance activities. Grant funds 
should be used to increase the level of expenditures from State, local, 
and other funding sources.
    Applicants may apply for either a prevention program grant or a 
surveillance grant, but NOT both. Applicants from State health agencies 
applying for prevention program grant funds must address surveillance 
issues in their application.
    Awards will be made with the expectation that program activities 
will continue when grant funds are terminated.

Note

     Grant funds may not be expended for medical care and 
treatment or for environmental remediation of lead sources. However, 
the applicant must provide an acceptable plan to ensure that these 
program activities are appropriately carried out.
     Not more than 10 percent (exclusive of Direct 
Assistance) of any grant may be obligated for administrative costs. 
This 10 percent limitation is in lieu of, and replaces, the indirect 
cost rate.

Background and Definitions

Background

    State and community health agencies have traditionally been the 
principal delivery points for childhood lead screening and related 
medical and environmental management activities; however, limited 
resources and changing public health infrastructures have required 
public health agencies to develop new strategies to ensure the delivery 
of comprehensive services to prevent childhood lead poisoning.
    In 1991, CDC recommended universal screening for children under six 
years old except in communities where the prevalence of elevated blood 
lead levels was known to be very low. In areas where the majority of 
children are at low risk for lead exposure, universal screening is not 
a practical or cost-beneficial investment of limited resources. Thus, 
screening activities should be targeted to children at elevated risk of 
lead exposure. As the prevalence of blood lead levels continues to 
diminish in the United States, targeting screening to those children 
who remain at elevated risk of lead exposure will become increasingly 
important.
    Based on this scientific information and practical experience, to 
prevent childhood lead poisoning State and community health agencies 
will need to

[[Page 5425]]

re-examine their current screening policies and practices. State and 
local health agencies must have in place sound policies and programs to 
assess the risk for lead exposure and assure that appropriate and 
timely actions take place to protect children at risk of lead exposure. 
As State and local health departments revise their screening policies, 
it is anticipated that the screening and follow-up of children who most 
need services will be expanded or enhanced, thereby diminishing the 
screening of children in areas where they are not exposed to lead.
    Blood lead levels in the United States have fallen dramatically 
over the past decade--by about 78 percent between 1978 and 1991. 
Nevertheless, the Third National Health and Nutrition Examination 
Survey (NHANES III) shows that, despite a dramatic decline in lead 
exposure among children, approximately 1.7 million children ages 1-5 
still have blood lead levels 10 g/dL, a level at 
which there has been shown to be subtle effects on children's cognitive 
development. Poor, urban, black children and Mexican-American children 
are at especially high risk for harmful levels of lead in their blood.
    We have made great progress in reducing lead in important sources 
for the U.S. population--gasoline and food. However, there are still 
important sources of lead that pose a serious health threat to 
children. The remaining sources of lead exposure for children--lead in 
paint, dust, and soil--are far more difficult to address, since these 
can only be reduced by actions in individual homes. Without a concerted 
effort to reduce exposure from these sources, elevated lead levels in 
children will continue to be a public health problem.

Definitions

    Program: A designated unit within an agency responsible for 
implementing and coordinating a systematic and comprehensive approach 
to prevent childhood lead poisoning in high-risk communities.
    Program Elements: Include (1) identifying infants and young 
children with elevated blood lead levels, (2) identifying and assuring 
the remediation of possible sources of lead exposure throughout the 
community, (3) monitoring the medical and environmental management of 
lead poisoned children, (4) providing information on childhood lead 
poisoning and its prevention and management to the public, health 
professionals, and policy and decision makers, (5) encouraging and 
supporting community-based programs directed to the goal of eliminating 
childhood lead poisoning, (6) developing and providing laboratory 
support, and (7) maintaining a data management component that assists 
in the day-to-day management of the childhood lead poisoning prevention 
program and documents program activities.
    High-Risk or Targeted Community: Geographically defined 
community or neighborhood where there is significant childhood lead 
exposure (documented by the presence of children with elevated blood 
lead levels) or potential childhood lead exposure (documented by the 
presence of sources of lead exposure, especially older, deteriorating 
housing.)
    Lead Hazard: Accessible paint, dust, soil, water, or other 
source or pathway that contains lead or lead compounds that can 
contribute to or cause lead poisoning.
    Lead Hazard Remediation: The elimination, reduction, or 
containment of known and accessible lead sources.
    Care coordination: The total care of a child with lead 
poisoning, including appropriate and timely medical and environmental 
follow-up.
    Surveillance: For the purpose of this program, a complete 
PbB surveillance activity is defined as a process which: (1) 
systematically collects information over time about children with 
elevated PbB levels using laboratory reports as the data source; (2) 
provides for the follow-up of cases, including field investigations 
when necessary; and (3) provides timely and useful analysis and 
reporting of the accumulated data including an estimate of the rate of 
elevated PbB levels among all children receiving blood tests.

Purpose

Prevention Grant Program

    The purpose of this grant program is to provide impetus for the 
development and operation of State and community-based childhood lead 
poisoning prevention programs in places where there is a determined 
risk of childhood lead exposure and to develop Statewide capacity for 
conducting surveillance of elevated blood-lead levels.
    Grant-supported programs are expected to serve as catalysts and 
models for the development of non-grant-supported programs and 
activities in other States and communities. Further, grant-supported 
programs should create community awareness of the problem (e.g., among 
community and business leaders, medical community, parents, educators, 
and property owners). It is expected that State health agencies will 
play a lead role in the development of community-based childhood lead 
poisoning prevention programs, including ensuring coordination and 
integration with maternal and child health programs; State Medicaid 
Early Periodic Screening, Diagnosis, and Treatment, (EPSDT) programs; 
community and migrant health centers; and community-based organizations 
providing health and social services in or near public housing units, 
as authorized under Section 340A of the PHS Act.
    The prevention grant program will provide financial assistance and 
support to State and local government agencies to:
    1. Establish, expand, or improve services to assure that children 
in high risk areas are screened. Screening should focus on: (1) Making 
certain children not currently served by existing health care services 
are screened, (2) integrating screening efforts with maternal and child 
health programs; State Medicaid programs, such as the EPSDT programs; 
community and migrant health centers; and community-based organizations 
providing health and social services in or near public housing units, 
as authorized under Section 340A of the PHS Act, and (3) guaranteeing 
that high-risk children seen by private providers are screened.
    2. Intensify care coordination efforts to ensure that children with 
elevated blood lead levels receive appropriate and timely follow-up 
services.
    3. Establish, expand, or improve environmental investigations to 
rapidly identify and reduce sources of lead exposure throughout a 
community.
    4. Plan and develop activities for the primary prevention of 
childhood lead poisoning in demonstrated high-risk areas to be 
conducted in collaboration with other government and community-based 
organizations.
    5. Develop and implement efficient information management/data 
systems compatible with CDC guidelines for monitoring and evaluation.
    6. Improve the actions of other appropriate agencies and 
organizations to facilitate the rapid remediation of identified lead 
hazards in high-risk communities.
    7. Enhance knowledge and skills of program staff through training 
and other methods.
    8. Based upon program findings, provide information on childhood 
lead poisoning to the public, policy-makers, academic community, and 
other interested parties.
    9. Develop State-based systems for surveillance of blood lead 
levels among

[[Page 5426]]

children, and use surveillance data to assess prevention activities and 
target resources.

Surveillance Grant Funds

    The surveillance component of this announcement is intended to 
assist State health departments or other appropriate agencies to 
implement a complete surveillance activity for PbB levels in children. 
Development of surveillance systems at the local, State and national 
levels is essential for targeting interventions to high-risk 
populations and for tracking progress in eliminating childhood lead 
poisoning.
    The childhood blood-lead surveillance program has the following 
five goals:
    1. Increase the number of State health departments with 
surveillance systems for elevated PbB levels;
    2. Build the capacity of State-or territorial-based PbB level 
surveillance systems;
    3. Use data from these systems to conduct national surveillance of 
elevated PbB levels;
    4. Disseminate data on the occurrence of elevated PbB levels to 
government agencies, researchers, employers, and medical care 
providers; and
    5. Direct intervention efforts to reduce environmental lead 
exposure.

Program Requirements

    A copy of the Program Guidance Document will be included with the 
application package. Please refer to this document (Program Guidance) 
for important information and procedures in developing and completing 
your application.

Prevention Grant Program

    The following are requirements for Childhood Lead Poisoning 
Prevention Projects:
    1. A director/coordinator with authority and responsibility to 
carry out the requirements of the program.
    2. Provide qualified staff, other resources, and knowledge to 
implement the provisions of the program.
    3. Revise program efforts based on CDC's plans to issue new 
recommendations on childhood lead poisoning prevention.
    4. Provide a comprehensive statewide plan that includes strategies, 
identifies where lead exposed children are, and provides appropriate 
screening and timely follow-up for those children.
    5. Provide a plan to develop an automated data-management system 
designed to collect and maintain laboratory data on the results of 
blood lead testing and care coordination data for children with 
elevated blood lead levels. This automated data-management systems 
should be used to monitor and evaluate all major program activities and 
services.
    6. Establishment and maintenance of a system to monitor the 
notification and follow-up of children who are confirmed with elevated 
blood lead levels and who are referred to local Public Housing 
Authorities (PHAs).
    7. Effective, well-defined working relationships within public 
health agencies and with other agencies and organizations at national, 
State, and community levels (e.g., housing authorities, environmental 
agencies, maternal and child health programs, State Medicaid EPSDT 
programs; or, community and migrant health centers; community-based 
organizations providing health and social services in or near public 
housing units, as authorized under Section 340A of the PHS Act, State 
epidemiology programs, State and local housing rehabilitation offices, 
schools of public health and medical schools, and environmental 
interest groups) to appropriately address the needs and requirements of 
programs (e.g., data management systems to facilitate the follow-up and 
tabulation of children reported with elevated blood lead levels, 
training to ensure the safety of abatement workers) in the 
implementation of proposed activities. This includes the establishment 
of networks with other State and local agencies with expertise in 
childhood lead poisoning prevention programming.
    8. Assurances that income earned by the childhood lead poisoning 
prevention program is returned to the program for use by the program.
    9. For awards to State agencies, there must be a demonstrated 
commitment to provide technical, analytical, and program evaluation 
assistance to local agencies interested in developing or strengthening 
childhood lead poisoning prevention programs.
    10. SPECIAL REQUIREMENT regarding Medicaid provider-status of 
applicants: Pursuant to section 317A of the Public Health Service Act 
(42 U.S.C. 247b-1) as amended by Sec. 303 of the ``Preventive Health 
Amendments of 1992'' (Public Law 102-531), applicants AND current 
grantees must meet the following requirements: For Childhood Lead 
Poisoning Prevention Program services which are Medicaid-reimbursable 
in the applicant's State:
     Applicants who directly provide these services must be 
enrolled with their State Medicaid agency as Medicaid providers.
     Providers who enter into agreements with the applicant to 
provide such services must be enrolled with their State Medicaid agency 
as providers.
    An exception to this requirement will be made for providers whose 
services are provided free of charge and who accept no reimbursement 
from any third-party payer. Such providers who accept voluntary 
donations may still be exempted from this requirement.
    11. For State Prevention Programs, a Surveillance component defined 
as a process which: (1) Systematically collects information over time 
about children with elevated PbB levels using laboratory reports as the 
data source; (2) provides for the follow-up of cases, including field 
investigations when necessary; (3) provides timely and useful analysis 
and reporting of the accumulated data including an estimate of the rate 
of elevated PbB levels among all children receiving blood tests; and 
(4) reports data to CDC in the appropriate format.
    To achieve these goals, programs must be able to: (1) provide 
qualified staff, other resources, and knowledge to implement the 
provisions of this program. Applicants requesting grant supported 
positions must provide assurances that such positions will be approved 
by the applicant's personnel system; (2) revise, refine, and implement, 
in collaboration with CDC, the methodology for surveillance as proposed 
in the respective program application; (3) have demonstrated experience 
or access to professionals knowledgeable in conducting and evaluating 
public health programs; and (4) have the ability to translate data to 
State and local public health officials, policy and decision-makers, 
and to others seeking to strengthen program efforts.

For Surveillance Grants

    The following are requirements for surveillance only grant 
projects:
    1. A full-time director/coordinator with authority and 
responsibility to carry out the requirements of surveillance program 
activities.
    2. Ability to provide qualified staff, other resources, and 
knowledge to implement the provisions of this program. Applicants 
requesting grant supported positions must provide assurances that such 
positions will be approved by the applicant's personnel system.
    3. Effective, well-defined working relationships with childhood 
lead poisoning prevention programs within the applicant's State.
    4. Revise, refine, and implement, in collaboration with CDC, the 
methodology for surveillance as

[[Page 5427]]

proposed in the respective program application.
    5. Collaborate with CDC in any interim and/or final evaluation of 
the surveillance activity.
    6. Monitor and evaluate all major program activities and services.
    7. Demonstrated experience in conducting and evaluating public 
health programs or having access to professionals who are knowledgeable 
in conducting such activities.
    8. Ability to translate data to State and local public health 
officials, policy and decision-makers, and to others seeking to 
strengthen program efforts.

Technical Reporting Requirements

    Quarterly progress reports are required of all grantees. The 
quarterly report should not exceed 25 pages. Time lines for the 
quarterly reports will be established at the time of award, but are 
typically due 30 days after the end of each calendar quarter. A 
progress report is required as a part of the continuation application. 
Note that surveillance only grantees are not required to submit 
quarterly quantitative data.
    Annual Financial Status Reports (FSRs) are due 90 days after the 
end of the budget period. The final progress report and FSR shall be 
prepared and submitted no later than 90 days after the end of the 
project period. Submit the original and 2 copies of the reports to the 
Grants Management Office indicated under ``Where to Obtain Additional 
Information'' section.

Evaluation Criteria

    The review of applications will be conducted by an objective review 
committee who will review the quality of the application based on the 
strength and completeness of the plan submitted. The budget 
justification will be used to assess how well the technical plan is 
likely to be carried out using available resources. The maximum ratings 
score of an application is 100 points.

A. The Factors To Be Considered in the Evaluation of Prevention Program 
Grant Applications Are:

    1. Evidence of the Childhood Lead Poisoning Problem (40 points).
    (a) Applicants should describe and document the extent of the 
problem as defined by data from recent screening, demographic, 
environmental, and other data. (Population-based data or estimates 
should be compared to NHANES III data discussed in the Background and 
Definition Section of this program announcement). (20 points)
    (b) Applicants' ability to identify high-risk targeted areas within 
their public health jurisdictions defined by such factors as: evidence 
of children with elevated blood lead levels, documentation of pre-1950 
housing and/or other evidence of old, deteriorating houses as well as 
the percent and number of children under six years of age living in 
poverty. Other known or suspected sources of lead poisoning should also 
be discussed. (20 points)
    2. Technical Approach (30 points).
    The quality of the technical approach in carrying out the proposed 
activities including:
    (a) Goals and Objectives: The extent to which the applicant has 
included clearly identified goals and objectives which are specific, 
measurable, and relevant to the purpose of this proposal (10 points).
    (b) Approach: The extent to which the applicant provides a detailed 
description of the proposed activities which are likely to achieve each 
objective for the budget period (10 points).
    (c) Timeline: The extent to which the applicant provides a 
reasonable schedule for implementation of the activities (5 points).
    (d) Evaluation: The extent to which the evaluation plan addresses 
the achievement of objectives (5 points).
    3. Applicant Capability (10 points).
    Capability of the applicant to initiate and carry out proposed 
program activities successfully within the time frames set forth in the 
application. Proposed staff skills must match the proposed program of 
work described. Elements to consider include:
    (a) Demonstrated knowledge and experience of the proposed project 
director or manager and staff in planning and managing large and 
complex interdisciplinary programs involving public health, 
environmental management, and housing rehabilitation. The percentage of 
time the project manager will devote to this project is a significant 
factor, and must be indicated (5 points).
    (b) Written assurances that proposed positions can and will be 
filled as described in the application (3 points).
    (c) Evidence of institutional capacity, demonstrated by the 
experience and continuing capability of the jurisdiction, to initiate 
and implement similar environmental and housing projects. The applicant 
should describe these related efforts and the current capacity of its 
agency (2 points).
    4. Collaboration (20 points).
    (a) Extent to which the applicant demonstrates that proposed 
activities are being conducted in conjunction with, or through, 
organizations with known and established ties in the target 
communities. Evidence of support and participation from appropriate 
community-based or neighborhood-based organizations in the form of 
memoranda of understanding or other agreements of collaboration. (10 
points)
    (b) Extent to which the applicant documents established 
collaboration with appropriate governmental agencies responding to 
childhood lead poisoning prevention issues such as environmental 
health, housing, medical management, etc., through specific commitments 
for consultation, employment, or other activities, as evidenced by the 
names and proposed roles of these participants and letters of 
commitment. Absence of letters describing specific participation will 
result in a reduced rating under this factor. (10 points)
    5. Budget Justification and Adequacy of Facilities (NOT SCORED).
    The budget will be evaluated for the extent to which it is 
reasonable, clearly justified, and consistent with the intended use of 
grant funds. The adequacy of existing and proposed facilities to 
support program activities also will be evaluated.

B. The Factors to be Considered in the Evaluation of Applications for 
Surveillance Program Grant Applications are:

    1. Surveillance Activity : (35 points).
    The clarity, feasibility, and scientific soundness of the 
surveillance approach. Also, the extent to which a proposed schedule 
for accomplishing each activity and methods for evaluating each 
activity are clearly defined and appropriate. The following points will 
be specifically evaluated:
    (a) How laboratories report PbB levels.
    (b) How data will be collected and managed.
    (c) How the quality of data and completeness of reporting will be 
assured.
    (d) How and when data will be analyzed.
    (e) How summary data will be reported and disseminated.
    (f) Protocols for follow-up of individuals with elevated PbB 
levels.
    (g) Provisions to obtain denominator data.
    2. Progress Toward Complete Blood-Lead Surveillance (30 points).
    The extent to which the proposed activities are likely to result in 
substantial progress towards establishing a complete State-based PbB 
surveillance activity (as defined in the ``Purpose'' section).
    3. Project Sustainability (20 points).
    The extent to which the proposed activities are likely to result in 
the long-

[[Page 5428]]

 term maintenance of a complete State-based PbB surveillance system. In 
particular, specific activities that will be undertaken by the State 
during the project period to ensure that the surveillance program 
continues after completion of the project period.
    4. Personnel (10 points).
    The extent to which the qualifications and time commitments of 
project personnel are clearly documented and appropriate for 
implementing the proposal.
    5. Use of Existing Resources (5 points).
    The extent to which the proposal would make effective use of 
existing resources and expertise within the applicant agency or through 
collaboration with other agencies.
    6. BUDGET (Not Scored).
    The extent to which the budget is reasonable, clearly justified, 
and consistent with the intended use of funds.

Executive Order 12372 Review

    Applications are subject to Intergovernmental Review of Federal 
Programs as governed by Executive Order (E.O.) 12372. E.O. 12372 sets 
up a system for State and local government review of proposed Federal 
assistance applications. Applicants should contact their State Single 
Point of Contact (SPOC) as early as possible to alert them to the 
prospective applications and receive any necessary instructions on the 
State process. For proposed projects serving more than one State, the 
applicant is advised to contact the SPOC for each affected State. A 
current list of SPOCs is included in the application kit. If they have 
comments it should be sent to Lisa G. Tamaroff, Grants Management 
Specialist, Grants Management Branch, Procurement and Grants Office, 
Centers for Disease Control and Prevention (CDC), 255 East Paces Ferry 
Road, NE., Atlanta, GA 30305, no later than 60 days after the 
application due date. The Program Announcement Number and Program Title 
should be referenced on the document. The granting agency does not 
guarantee to ``accommodate or explain'' State process recommendations 
it receives after that date.

Public Health System Reporting Requirement

    This program is not subject to the Public Health System Reporting 
Requirements.

Catalog of Federal Domestic Assistance Number

    The Catalog of Federal Domestic Assistance number is 93.197.

Other Requirements

Paperwork Reduction Act

    Projects that involve the collection of information from 10 or more 
individuals and funded by the grant will be subject to review by the 
Office of Management and Budget(OMB)under the Paperwork Reduction Act.

Application Submission and Deadline

    The original and two copies of the PHS 5161-1 (OMB Number 0937-
0189) must be submitted to Lisa G. Tamaroff, Grants Management 
Specialist, Grants Management Branch, Procurement and Grants Office, 
Centers for Disease Control and Prevention (CDC), 255 East Paces Ferry 
Road, NE., Room 300, Atlanta, GA 30305, on or before April 9, 1997.

1. Deadline

    Applications shall be considered as meeting the deadline if they 
are either:
    A. Received on or before the deadline date, or
    B. Sent on or before the deadline date and received in time for 
submission for the review process. Applicants must request a legibly 
dated U.S. Postal Service Postmark or obtain a legibly dated receipt 
from a commercial carrier or U.S. Postal Service. Private metered 
postmarks shall not be acceptable as proof of timely mailing.

2. Late Applications

    Applications which do not meet the criteria in 1.A. or 1.B. above 
are considered late applications. Late applications will not be 
considered in the current competition and will be returned to the 
applicant.
    A one-page, single-spaced, typed abstract must be submitted with 
the application. The heading should include the title of the grant 
program, project title, organization, name and address, project 
director and telephone number.

Where to Obtain Additional Information

    To receive additional written information call (404) 332-4561. You 
will be asked to leave your name, address, and phone number and will 
need to refer to Announcement 721. You will receive a complete program 
description, information on application procedures and application 
forms.
    If you have questions after reviewing the contents of all 
documents, business management technical assistance may be obtained 
from Lisa G. Tamaroff, Grants Management Specialist, Grants Management 
Branch, Procurement and Grants Office, Centers for Disease Control and 
Prevention (CDC), 255 East Paces Ferry Road, NE., Room 300, Mailstop E-
13, Atlanta, GA 30305, telephone (404) 842-6796. Internet address 
[email protected].
    This and other CDC announcements are also available through the CDC 
homepage on the Internet. The address for the CDC homepage is http://
www.cdc.gov.
    CDC will not send application kits by facsimile or express mail.
    Please refer to Announcement Number 721 when requesting information 
and submitting an application.
    Technical assistance on prevention activities may be obtained from 
Claudette A. Grant, Acting Chief, Program Services Section, Lead 
Poisoning Prevention Branch, Division of Environmental Hazards and 
Health Effects, National Center for Environmental Health, Centers for 
Disease Control and Prevention (CDC), 4770 Buford Highway, NE., 
Mailstop F-42, Atlanta, GA 30341-3724, telephone (770) 488-7330, 
Internet address [email protected].
    Technical assistance on surveillance activities may be obtained 
from Carol Pertowski, M.D., Medical Epidemiologist, Surveillance and 
Programs Branch, Division of Environmental Hazards and Health Effects, 
National Center for Environmental Health, Centers for Disease Control 
and Prevention (CDC), 4770 Buford Highway, NE., Mailstop F-42, Atlanta, 
GA 30341-3724, telephone (770) 488-7330, Internet address 
[email protected].
    Potential applicants may obtain a copy of Healthy People 2000 (Full 
Report, Stock No. 017-001-00474-0) or Healthy People 2000 (Summary 
Report, Stock No. 017-001-00473-1) through the Superintendent of 
Documents, Government Printing Office, Washington, DC 20402-9325, 
telephone (202) 512-1800.

    Dated: January 30, 1997.
Joseph R. Carter,
Acting Associate Director, Management and Operations, Centers for 
Disease Control and Prevention.
[FR Doc. 97-2799 Filed 2-4-97; 8:45 am]
BILLING CODE 4163-18-P